AT315865B - Verfahren zur Herstellung neuer substituierter Chinoxalin- 1,4-dioxyde und deren Salze - Google Patents

Verfahren zur Herstellung neuer substituierter Chinoxalin- 1,4-dioxyde und deren Salze

Info

Publication number
AT315865B
AT315865B AT191571A AT191571A AT315865B AT 315865 B AT315865 B AT 315865B AT 191571 A AT191571 A AT 191571A AT 191571 A AT191571 A AT 191571A AT 315865 B AT315865 B AT 315865B
Authority
AT
Austria
Prior art keywords
dioxides
salts
production
new substituted
substituted quinoxaline
Prior art date
Application number
AT191571A
Other languages
English (en)
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Application granted granted Critical
Publication of AT315865B publication Critical patent/AT315865B/de

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D241/00Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/36Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems
    • C07D241/50Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings condensed with carbocyclic rings or ring systems with hetero atoms directly attached to ring nitrogen atoms
    • C07D241/52Oxygen atoms
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K20/00Accessory food factors for animal feeding-stuffs
    • A23K20/10Organic substances
    • A23K20/116Heterocyclic compounds
    • A23K20/137Heterocyclic compounds containing two hetero atoms, of which at least one is nitrogen
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23KFODDER
    • A23K50/00Feeding-stuffs specially adapted for particular animals
    • A23K50/30Feeding-stuffs specially adapted for particular animals for swines
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C271/00Derivatives of carbamic acids, i.e. compounds containing any of the groups, the nitrogen atom not being part of nitro or nitroso groups
    • C07C271/06Esters of carbamic acids
    • C07C271/08Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms
    • C07C271/10Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C271/16Esters of carbamic acids having oxygen atoms of carbamate groups bound to acyclic carbon atoms with the nitrogen atoms of the carbamate groups bound to hydrogen atoms or to acyclic carbon atoms to carbon atoms of hydrocarbon radicals substituted by singly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D263/00Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/08Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D263/10Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D263/14Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms with radicals substituted by oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/08Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D277/10Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Polymers & Plastics (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Food Science & Technology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
AT191571A 1970-03-18 1971-03-05 Verfahren zur Herstellung neuer substituierter Chinoxalin- 1,4-dioxyde und deren Salze AT315865B (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US2084270A 1970-03-18 1970-03-18
US2084170A 1970-03-18 1970-03-18

Publications (1)

Publication Number Publication Date
AT315865B true AT315865B (de) 1974-06-10

Family

ID=26693940

Family Applications (1)

Application Number Title Priority Date Filing Date
AT191571A AT315865B (de) 1970-03-18 1971-03-05 Verfahren zur Herstellung neuer substituierter Chinoxalin- 1,4-dioxyde und deren Salze

Country Status (13)

Country Link
JP (3) JPS5434756B1 (de)
AR (3) AR202999A1 (de)
AT (1) AT315865B (de)
BE (1) BE764088A (de)
CH (1) CH557356A (de)
DE (1) DE2111710C3 (de)
DK (1) DK131677C (de)
ES (1) ES388787A1 (de)
FR (1) FR2085717B1 (de)
GB (1) GB1330151A (de)
IT (1) IT1019008B (de)
NL (3) NL7102953A (de)
ZA (1) ZA711022B (de)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3870718A (en) * 1971-12-13 1975-03-11 Pfizer 2-imidazolidine substituted quinoxaline-1,4-dioxides and intermediates therefor
CH575213A5 (de) * 1972-09-05 1976-05-14 Ciba Geigy Ag
US4012512A (en) * 1972-09-05 1977-03-15 Ciba-Geigy Corporation Animal feeds containing quinoxaline-di-n-oxide derivatives
US4254120A (en) * 1978-12-19 1981-03-03 Ciba-Geigy Corporation Growth promoting quinoxaline-di-N-oxide carboxamides
JPS6147989U (ja) * 1984-09-04 1986-03-31 嶋田機器工業株式会社 ミシンにおける被縫布の押圧装置

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1058665B (de) * 1955-10-11 1959-06-04 Gen Aniline & Film Corp Trocknungsbeschleuniger fuer trocknende oder halbtrocknende OEle enthaltende Filmbildner
DE1670935C3 (de) * 1967-10-04 1975-12-04 Bayer Ag, 5090 Leverkusen 2-Methyl-3-carbonsäureamidochinoxalin-1,4-dl-N-oxide, ein Verfahren zu ihrer Herstellung und diese Verbindungen enthaltende antibakterielle Mittel

Also Published As

Publication number Publication date
AR204703A1 (es) 1976-02-27
NL7808009A (nl) 1978-11-30
ES388787A1 (es) 1974-02-01
CH557356A (fr) 1974-12-31
FR2085717B1 (de) 1975-06-06
NL7102953A (de) 1971-09-21
FR2085717A1 (de) 1971-12-31
DE2111710C3 (de) 1979-09-13
DE2111710B2 (de) 1979-01-25
NL7808008A (nl) 1978-11-30
JPS53127486A (en) 1978-11-07
GB1330151A (en) 1973-09-12
DK131677B (da) 1975-08-18
ZA711022B (en) 1971-12-29
BE764088A (fr) 1971-09-13
DE2111710A1 (de) 1971-09-30
AR202999A1 (es) 1975-08-08
JPS554749B2 (de) 1980-01-31
JPS554748B2 (de) 1980-01-31
IT1019008B (it) 1977-11-10
AR197977A1 (es) 1974-05-24
DK131677C (da) 1976-04-26
JPS53127487A (en) 1978-11-07
JPS5434756B1 (de) 1979-10-29

Similar Documents

Publication Publication Date Title
AT302276B (de) Verfahren zur Herstellung von neuen α-tert. Butylaminopropiophenonen und deren Säureadditionssalzen
AT317201B (de) Verfahren zur Herstellung neuer Imidazolderivate und ihrer Salze
AT310738B (de) Verfahren zur Herstellung neuer Benzimidazol-derivate und ihrer Salze
AT316563B (de) Verfahren zur herstellung von neuen 4-amino-6-aryl-pyrimidinen und von deren saeureadditionssalzen
AT324584B (de) Verfahren zur herstellung von neuen o-acyl-lysergolen und deren salzen
CH555346A (de) Verfahren zur herstellung neuer imine von 2-formylchinoxalin-di-n-oxidcarbonsaeure-(3) und deren salzen.
AT323152B (de) Verfahren zur herstellung neuer indolderivate und ihrer salze
AT297701B (de) Verfahren zur Herstellung neuer Bistriazolyl-bisphenyl-methanen und deren Salze
AT312580B (de) Verfahren zur Herstellung neuer p-Aminophenylamidine und deren Säureadditionssalze
AT322118B (de) Verfahren zur herstellung neuer alkaloidester vom eburnamintyp und deren salze
AT305263B (de) Verfahren zur Herstellung neuer, rechtsdrehender, basisch substituierter Phenylacetonitrile sowie deren Salze
AT315865B (de) Verfahren zur Herstellung neuer substituierter Chinoxalin- 1,4-dioxyde und deren Salze
AT313267B (de) Verfahren zur Herstellung neuer Nitrofuranderivate und deren Salze
AT289091B (de) Verfahren zur Herstellung neuer 4-Cyano-4-phenyl-aminocyclohexane und deren Salze
CH550186A (de) Verfahren zur herstellung von 5-imino-1.2.4-triazin-derivaten.
ATA10874A (de) Verfahren zur herstellung von neuen benzobicycloalkanaminen und deren saeureadditionssalzen
CH553150A (de) Verfahren zur herstellung von neuen polyamidammoniumverbindungen und deren verwendung.
AT308116B (de) Verfahren zur Herstellung neuer Chinoxalin-1,4-dioxyde und ihrer Salze
CH527821A (de) Verfahren zur Herstellung neuer 5,6-Dihydro-phenanthridin-Derivate und deren Herstellung
CH547845A (de) Verfahren zur herstellung neuer disazopigmente und deren verwendung.
AT306258B (de) Verfahren zur Herstellung neuer Tropan-3-ol-Derivate und deren Salze
AT316516B (de) Verfahren zur Herstellung von neuen Aminoalkoholen und von deren Säureadditionssalzen
AT255664B (de) Verfahren zur Herstellung neuer Yohimban-Derivate und deren Salze
AT307640B (de) Verfahren zur Herstellung von neuen 17-Aza-steroiden und deren Salzen
AT256870B (de) Verfahren zur Herstellung neuer Benzolsulfonylharnstoffe und deren Salzen

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee